153 related articles for article (PubMed ID: 16493564)
1. [Changeover to risperidone after treatment with conventional low potency neuroleptics in dementia patients. An observation study during usage].
Stoppe G; Schreiner A; Schmitt AB
Dtsch Med Wochenschr; 2006 Mar; 131(9):423-9. PubMed ID: 16493564
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric out-patients].
Kurz A; Delius-Stute H; Rettig K; Schwalen S
MMW Fortschr Med; 2003 Oct; 145 Suppl 3():89-95. PubMed ID: 15490773
[TBL] [Abstract][Full Text] [Related]
3. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
Tune LE
J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
Onor ML; Saina M; Trevisiol M; Cristante T; Aguglia E
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):205-9. PubMed ID: 17020789
[TBL] [Abstract][Full Text] [Related]
6. Risperidone use in Korean patients with Alzheimer's disease: optimal dosage and effect on behavioural and psychological symptoms, cognitive function and activities of daily living.
Yoon JS; Kim JM; Lee H; Shin IS; Choi SK
Hum Psychopharmacol; 2003 Dec; 18(8):627-33. PubMed ID: 14696022
[TBL] [Abstract][Full Text] [Related]
7. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
[TBL] [Abstract][Full Text] [Related]
8. Mortality in elderly dementia patients treated with risperidone.
Haupt M; Cruz-Jentoft A; Jeste D
J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812
[TBL] [Abstract][Full Text] [Related]
9. [New therapeutic strategies for behavioral and psychological symptoms of dementia].
Ikeda M
Rinsho Shinkeigaku; 2005 Nov; 45(11):861-3. PubMed ID: 16447746
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations, therapeutic response and side effects in children and adolescents with impulsive-aggressive symptoms during risperidone therapy.
Klampfl K; Taurines R; Preuss A; Burger R; Rothenhöfer S; Wewetzer Ch; Pfuhlmann B; Fegert J; Gerlach M; Mehler-Wex C
Pharmacopsychiatry; 2010 Mar; 43(2):58-65. PubMed ID: 20336598
[TBL] [Abstract][Full Text] [Related]
11. Risperidone and dementia-related aggression: new indication. A last resort, no better than haloperidol.
Prescrire Int; 2009 Dec; 18(104):248. PubMed ID: 20025088
[TBL] [Abstract][Full Text] [Related]
12. [Risperidone in the ambulatory treatment of behavior disorders in demented patients of Alzheimer's type: a retrospective analysis].
Sobów TM; Kłoszewska I
Psychiatr Pol; 2001; 35(6):1033-45. PubMed ID: 11877883
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptics for behavioral symptoms of dementia.
Reynolds PL; Strayer SM
J Fam Pract; 2000 Jan; 49(1):78-9. PubMed ID: 10678345
[No Abstract] [Full Text] [Related]
14. Open-label, observational study of the effects of risperidone on the behavioral and psychological symptoms of dementia and caregiver stress in the community setting.
Arriola E; Ignacio Diago J; Antonio Burón J; Gallego R;
Am J Geriatr Pharmacother; 2005 Mar; 3(1):8-16. PubMed ID: 16089242
[TBL] [Abstract][Full Text] [Related]
15. The treatment of psychotic disorders in late life.
Thorpe L
Can J Psychiatry; 1997 Jun; 42 Suppl 1():19S-27S. PubMed ID: 9220126
[TBL] [Abstract][Full Text] [Related]
16. [Atypical neuroleptics in dementia. Managing behavioral disorders early and efficiently].
MMW Fortschr Med; 2002 Mar; 144(10):60-1. PubMed ID: 11928271
[No Abstract] [Full Text] [Related]
17. Risperidone is effective for wandering and disturbed sleep/wake patterns in Alzheimer's disease.
Meguro K; Meguro M; Tanaka Y; Akanuma K; Yamaguchi K; Itoh M
J Geriatr Psychiatry Neurol; 2004 Jun; 17(2):61-7. PubMed ID: 15157345
[TBL] [Abstract][Full Text] [Related]
18. Initial treatment of severe acute psychosis with fast orally disintegrating risperidone tablets.
Normann C; Schmauss M; Bakri N; Gerwe M; Schreiner A
Pharmacopsychiatry; 2006 Nov; 39(6):209-12. PubMed ID: 17124642
[TBL] [Abstract][Full Text] [Related]
19. How safe are antipsychotics in dementia?
BMJ Group
Drug Ther Bull; 2007 Nov; 45(11):81-5. PubMed ID: 18165678
[TBL] [Abstract][Full Text] [Related]
20. Amisulpride versus risperidone treatment for behavioral and psychological symptoms in patients with dementia of the Alzheimer type: a randomized, open, prospective study.
Lim HK; Pae CU; Lee C; Lee CU
Neuropsychobiology; 2006; 54(4):247-51. PubMed ID: 17356308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
